Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Anti-inflammatory and/or anti-allergic oral care product or medicine

An oral care and anti-allergy technology, applied in the field of medicine, can solve the problems of single nursing effect, slow effect, and insignificant effect.

Pending Publication Date: 2020-06-09
广西英路维特药物有限公司
View PDF12 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of the existing functional oral care products can only play a relatively single nursing effect, and it is difficult to really play anti-inflammatory and anti-allergic effects at the same time.
Moreover, most of the existing functional oral care products have complex components, slow effects, and inconspicuous effects, which cannot meet the needs of consumers.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-inflammatory and/or anti-allergic oral care product or medicine
  • Anti-inflammatory and/or anti-allergic oral care product or medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 Preparation of the mouthwash of the present invention

[0024] Adding Pulsatilla saponins B4 to physiological saline and mixing uniformly, controlling the weight ratio of Pulsatilla saponins B4 to 0.5‰ or 1‰ of the total weight to obtain 0.5‰ mouthwash or 1‰ mouthwash of the present invention, respectively.

Embodiment 2

[0025] Example 2 Preparation of toothpaste of the present invention

[0026] Pulsatilla saponin B4 is added to untreated toothpaste, mixed uniformly, and the weight ratio of Pulsatilla saponin B4 is controlled to be 0.5‰ or 1‰ of the total weight to obtain 0.5‰ toothpaste or 1‰ toothpaste of the present invention, respectively.

[0027] Among them, the untreated toothpaste is made of calcium carbonate (39.0wt.%), sorbitol (22.0wt.%), sodium carboxymethyl cellulose (1.1wt.%), sodium lauryl sulfate (1.3wt.%), A common toothpaste prepared from saccharin (0.1wt.%), flavor (1.0wt.%), ethyl paraben (less than 0.3wt.%) and deionized water.

[0028] The following experimental examples demonstrate the beneficial effects of the present invention.

experiment example 1

[0029] Experimental example 1 Anti-inflammatory effect test of the toothpaste of the present invention

[0030] (1) Test subjects: 15 samples of patients were randomly selected; symptoms: gum inflammation, pain, redness and swelling.

[0031] (2) Test samples: 0.5‰ toothpaste and 1‰ toothpaste prepared in Example 2 of the present invention; commercially available anti-inflammatory toothpaste (Colgate).

[0032] (3) Experimental method: The patients were randomly divided into 3 groups. The first group used commercially available anti-inflammatory toothpaste to brush their teeth, the second group used 0.5‰ toothpaste of the present invention to brush their teeth, and the third group used 1‰ toothpaste of the present invention to brush their teeth. Each time, the amount of toothpaste is 2cm, and each brushing takes 5 minutes. Observe the gum recovery and recovery time of the sick person.

[0033] Criteria for recovery: gum pain disappeared, redness and swelling subsided.

[0034] (4) Exp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an anti-inflammatory and / or anti-allergic oral care product or medicine. The oral care product or medicine contains anemoside B4. The invention also provides an application of the anemoside B4 in preparation of the anti-inflammatory and / or anti-allergic oral care product or medicine. Experimental results show that after the anemoside B4 is added into an oral care product, gum inflammation, pain, redness and swelling symptoms can be treated, gum bleeding symptoms can be treated, and the anti-inflammatory anti-allergic effects of the oral care product can be significantlyimproved in a short time. Therefore, the anemoside B4 as an active ingredient has very good application prospects in the preparation of the anti-inflammatory anti-allergic oral care product or medicine.

Description

Technical field [0001] The invention belongs to the field of medicine, and specifically relates to an anti-inflammatory and / or anti-allergic oral care product or medicine. Background technique [0002] 90% of adults in China have different degrees of oral problems. According to professional medical statistics, with changes in eating habits and increased work pressure, oral ulcers, swelling and pain, bleeding, atrophy and other oral problems are spreading rapidly. At the same time, common oral diseases such as gingivitis, periodontitis and alveolar abscess caused by chemical drugs, burns, vitamin C deficiency, and bacterial growth in the oral cavity are also increasing. [0003] In order to prevent or alleviate the above oral problems in daily life, a dazzling array of functional oral care products have appeared on the market, such as anti-allergic toothpaste and anti-inflammatory mouthwash. However, most of the existing functional oral care products can only play a relatively sing...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61K8/60A61P1/02A61P7/04A61P29/00A61P37/08A61Q11/00
CPCA61K31/704A61K8/602A61Q11/00A61P1/02A61P29/00A61P37/08A61P7/04A61K2800/28
Inventor 苏柘僮赵俊卿杨世林
Owner 广西英路维特药物有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products